Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Vera Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Share |
Maximum Offering Price |
Fee Rate | Amount of Registration Fee(1) | |||||||||
| Fees to be Paid | Equity | Class A Common stock, par value $0.001 per share |
Rule 457(r) | 8,214,286(2) | $42.00 | $345,000,012 | 0.00015310 | $52,819.51 | ||||||||
| Total Offering Amounts | — | $345,000,012 | — | $52,819.51 | ||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||
| Total Fee Offsets | — | — | ||||||||||||||
| Net Fee Due | — | $52,819.51 | ||||||||||||||
| (1) | Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). Payment of the registration fee at the time of filing of the registrant’s Registration Statement on Form S-3 (File No. 333-282861) on October 28, 2024 was deferred pursuant to Rules 456(b) and 457(r) under the Securities Act and is paid herewith. |
| (2) | Includes 1,071,428 shares of Class A common stock that the underwriters have an option to purchase. |